争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
返回词条共 5 条
2026
2026
Hims & Hers Health 遭提起证券集体诉讼
提起诉讼
Hims & Hers Health, Inc.（NYSE: HIMS）遭证券集体诉讼，代表2025年8月4日至2026年7月29日期间购买或以其他方式取得该公司证券的投资者。诉状指控被告作出重大虚假和/或误导性陈述并未披露重大不利事实，包括该公司将消费者健康信息共享给第三方广告平台，以及在告知消费者可咨询医疗服务提供者的情况下，在消费者提交问诊表后几乎立即收取处方费。Wolf Haldenstein Adler Freeman & Herz律师事务所宣布该诉讼，首席原告截止日期为2026年11月2日。该诉讼紧随2026年7月29日FTC、加利福尼亚州及犹他州消费者保护部门对Hims & Hers提起的执法诉讼（指控欺骗性收费、取消订阅困难及误导性隐私做法），当日该公司股价下跌14.73%至25.00美元收盘。
品牌回应
否认 — Hims & Hers
Hims pushed back, saying the FTC disregarded evidence it provided during the agency’s three-year investigation and “ignored” telehealth industry standards
澄清 — Hims & Hers
The company said its privacy policy lets patients choose how their data is used and called the suit an attempt to generate headlines rather than protect consumers.
来源摘录
The FTC also alleges that the company has made it difficult for consumers to cancel subscriptions and misled consumers about keeping their health information private.
The lawsuit, joined by California and Utah, was filed Wednesday in federal court in Northern California.
The FTC also alleges Hims shared sensitive health information with third-party advertising platforms owned by Meta and Snap, despite promising to protect patient privacy.
2025
2025
2025